IDT Biologika, along with State and Local Officials, to Mark Official Commencement of U.S. Vaccine Operations with Site Dedication at Rockville Manufacturing Facility

MEDIA ALERT

IDT Biologika, along with State and Local Officials, to Mark Official Commencement of U.S. Vaccine Operations with Site Dedication at Rockville Manufacturing Facility

WHAT:

IDT Biologika—a global health company – is hosting a dedication ceremony for its first U.S. manufacturing facility. IDT Biologika is an innovative, privately-held company with more than 90 years of experience researching, developing, manufacturing and marketing biologics for the global protection of human and animal health. 

WHEN:

Tuesday, September 22, 2015 at 9:45 a.m. ET 

WHERE:                 

1405 Research Boulevard, Rockville, Maryland 

WHO:                      

Remarks by:
Dr. Ralf Pfirmann, President, IDT Biologika Corporation
Benjamin H. Wu, Deputy Secretary, Maryland Department of Business and Economic Development
Bridget Donnell, Newton Mayor, City of Rockville
Jacqueline E. Shea, Ph.D., Chief Executive Officer, Aeras
Dr. Pfirmann is available for telephone interviews on September 21 and 22.

Media Contact: 
Mike Beyer
Sam Brown Inc.
312-961-2502
[email protected]

Suggested Articles

The FDA asked five drugmakers to pull their version of extended-release metformin off U.S. shelves after finding carcinogen contamination.

The FDA backtracked on its earlier testing and found NDMA contamination in the extended release formulation of certain generic versions of metformin.

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.